Skip to content

West Pharmaceutical Services

US · WST #752 by market cap Listed 1970
390.30 -6.39 -1.61%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
B
Momentum strategy signal
Hold
Analyst consensus
Buy

Mostly aligned, one view stands apart.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

✦ Quant Analyst Revision Trend how this is computed

Improving
2
■ Upgrades■ Downgrades
  • 2 upgrades vs 0 downgrades among tracked analyst rating changes.
  • Most recent: Morgan Stanley moved from Hold to Buy on 2026-09-22.

Analyst consensus 6 analysts

Buy
Avg price target 478.17 +22.5%
Price target rangecurrent 390.30
Low400.00
Avg478.17
High500.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-10-30 UBS -- Buy 495.00
2026-10-30 Evercore -- Buy 480.00
2026-10-30 Citi -- Buy 494.00
2026-10-30 Barclays -- Buy 500.00
2026-10-29 TD Cowen -- Buy 500.00
2026-10-29 Citi -- Buy 494.00
2026-10-13 TD Cowen -- Buy 420.00
2026-10-07 Barclays -- Buy 440.00
2026-09-22 Morgan Stanley -- Buy 400.00
2026-09-14 Morgan Stanley -- Hold 365.00
2026-09-09 UBS -- Buy 415.00
2026-08-03 Citi -- Buy 412.00
2026-07-27 Evercore -- Buy 425.00
2026-07-24 BofA Securities -- Buy 410.00
2026-07-24 Barclays -- Buy 400.00
2026-07-23 TD Cowen -- Buy 410.00
2026-07-23 William Blair -- Buy --
2026-07-23 Evercore -- Buy 410.00
2026-07-15 TD Cowen -- Buy 410.00
2026-07-13 BNP Paribas -- Buy 447.00
2026-07-09 Morgan Stanley -- Hold 365.00
2026-07-06 Evercore -- Buy 410.00
2026-07-02 KeyBanc -- Buy 390.00
2026-06-09 Barclays -- Buy 400.00
2026-06-02 BofA Securities -- Buy --

Price target trend monthly average, last 3 years

Recent rating changes

DateFirmChangeTarget
2026-09-22 Morgan Stanley Hold → Buy 400.00
2026-06-09 Barclays Hold → Buy 400.00

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-10-29 -- ±8.61% +3.23% (in line)
2026/Q2 2026-07-23 -- ±9.30% -0.82% (in line)
2026/Q1 2026-04-23 -- ±10.24% +12.86% (beat)
2025/Q4 2026-02-12 -- ±10.29% -1.04% (in line)
2025/Q3 2025-10-23 -- ±11.14% +10.92% (in line)
2025/Q2 2025-07-24 -- ±12.65% +22.78% (beat)
2025/Q1 2025-04-24 -- ±13.68% -3.48% (in line)
2024/Q4 2025-02-13 -- ±9.30% -38.22% (beat)
2024/Q3 2024-10-24 -- ±11.95% +15.43% (beat)
2024/Q2 2024-07-25 -- ±9.48% -14.40% (beat)
2024/Q1 2024-04-25 -- ±7.46% -4.55% (in line)
2023/Q4 2024-02-15 -- ±6.25% -14.08% (beat)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

West Pharmaceutical Services discussion 0 comments

Add a comment